Apramycin

Apramycin is an aminoglycoside antibiotic that is used in veterinary medicine, particularly for the treatment of bacterial infections in livestock. It is known for its effectiveness against a wide range of Gram-negative bacteria, including strains that are resistant to other aminoglycosides. Apramycin works by binding to the bacterial ribosome, interfering with protein synthesis and ultimately leading to bacterial cell death.

Mechanism of Action

Apramycin exerts its antibacterial effects by binding to the 16S rRNA component of the 30S subunit of the bacterial ribosome. This binding interferes with the initiation complex of protein synthesis, causing misreading of mRNA. As a result, defective proteins are synthesized, which disrupts bacterial cell membrane integrity and leads to cell death. This mechanism is similar to other aminoglycosides, but apramycin has a unique binding site and properties that confer effectiveness against some aminoglycoside-resistant bacteria.

Spectrum of Activity

The spectrum of activity of apramycin includes a broad range of Gram-negative bacteria such as Escherichia coli, Salmonella spp., and Klebsiella spp. It is also active against certain Gram-positive bacteria, although its primary use is against Gram-negative infections. Apramycin's effectiveness against multi-resistant strains makes it a valuable antibiotic in veterinary medicine.

Pharmacokinetics

The pharmacokinetic properties of apramycin are characterized by rapid absorption and distribution in animals following parenteral administration. It is primarily excreted unchanged in the urine, indicating that renal clearance is the main route of elimination. The drug's half-life in the body allows for dosing that can effectively maintain therapeutic levels without leading to accumulation and toxicity.

Clinical Uses

Apramycin is used predominantly in veterinary medicine for the treatment of bacterial infections in cattle, pigs, and poultry. It is effective against enteric infections caused by susceptible strains of bacteria, including neonatal diarrhea in pigs and calves and respiratory tract infections. Due to concerns about antibiotic resistance, its use is regulated, and it should be administered based on susceptibility testing.

Resistance

As with other antibiotics, the use of apramycin has led to the development of resistance among some bacterial populations. Resistance mechanisms include mutations in the ribosomal binding site and enzymatic modification of the drug, rendering it ineffective. Monitoring and prudent use of apramycin are essential to minimize the development and spread of resistance.

Safety and Side Effects

Aminoglycosides, including apramycin, can cause nephrotoxicity and ototoxicity. However, apramycin is generally considered to have a lower risk of these side effects compared to other aminoglycosides. Veterinary supervision and adherence to recommended doses are crucial to minimize the risk of adverse effects.

Regulatory Status

The use of apramycin in veterinary medicine is subject to regulatory approval and restrictions in many countries. Its use in food-producing animals is regulated to ensure that residues in food products do not pose a risk to human health. Withdrawal times are established to ensure that the drug has been sufficiently metabolized before the animal is slaughtered for food.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian